Mechanism of Pseudomonas aeruginosa persistence during treatment with broad-spectrum cephalosporins of lung infections in patients with cystic fibrosis.
AUTOR(ES)
Schryvers, A B
RESUMO
Beta-lactam resistance in Pseudomonas aeruginosa detected only during ceftazidime therapy of cystic fibrosis patients was studied. Evaluation of resistant and susceptible isolates from one patient and resistant laboratory derivatives indicated that elevated beta-lactamase levels were the primary determinant of resistance. Susceptible isolates outgrew resistant isolates on antibiotic-free medium.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174959Documentos Relacionados
- Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.
- Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins.
- Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.
- Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.
- Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins.
